Literature DB >> 25502003

Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening.

Karen Arnovitz Grinzaid1, Patricia Zartman Page, Jessica Johnson Denton, Jessica Ginsberg.   

Abstract

Ethnicity-based carrier screening for the Ashkenazi Jewish population has been available and encouraged by advocacy and community groups since the early 1970's. Both the American College of Medical Genetics and the American Congress of Obstetricians and Gynecologists recommend carrier screening for this population (Obstetrics and Gynecology, 114(4), 950-953, 2009; Genetics in Medicine, 10(1), 55-56, 2008). While many physicians inquire about ethnic background and offer appropriate carrier screening, studies show that a gap remains in implementing recommendations (Genetic testing and molecular biomarkers, 2011). In addition, education and outreach efforts targeting Jewish communities have had limited success in reaching this at-risk population. Despite efforts by the medical and Jewish communities, many Jews of reproductive age are not aware of screening, and remain at risk for having children with preventable diseases. Reaching this population, preferably pre-conception, and facilitating access to screening is critically important. To address this need, genetic counselors at Emory University developed JScreen, a national Jewish genetic disease screening program. The program includes a national marketing and PR campaign, online education, at-home saliva-based screening, post-test genetic counseling via telephone or secure video conferencing, and referrals for face-to-face genetic counseling as needed. Our goals are to create a successful education and screening program for this population and to develop a model that could potentially be used for other at-risk populations.

Entities:  

Mesh:

Year:  2014        PMID: 25502003     DOI: 10.1007/s10897-014-9800-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  11 in total

Review 1.  Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review.

Authors:  Lei-Shih Chen; Patricia Goodson
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

2.  An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests.

Authors:  Carlo Castellani; Sandra Perobelli; Vera Bianchi; Manuela Seia; Paola Melotti; Luisa Zanolla; Baroukh Maurice Assael; Faustina Lalatta
Journal:  Am J Med Genet A       Date:  2011-03-17       Impact factor: 2.802

3.  Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines.

Authors:  Diana Darcy; Lu Tian; Joanne Taylor; Iris Schrijver
Journal:  Genet Test Mol Biomarkers       Date:  2011-03-31

4.  ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

5.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

6.  Ashkenazi Jewish screening in the twenty-first century.

Authors:  Susan Klugman; Susan J Gross
Journal:  Obstet Gynecol Clin North Am       Date:  2010-03       Impact factor: 2.844

7.  Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.

Authors:  Adele Schneider; Sachiko Nakagawa; Rosanne Keep; Darnelle Dorsainville; Joel Charrow; Kirk Aleck; Jodi Hoffman; Sherman Minkoff; David Finegold; Wei Sun; Andrew Spencer; Johannah Lebow; Jie Zhan; Stephen Apfelroth; Nicole Schreiber-Agus; Susan Gross
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

8.  Attitudes and practices among internists concerning genetic testing.

Authors:  Robert Klitzman; Wendy Chung; Karen Marder; Anita Shanmugham; Lisa J Chin; Meredith Stark; Cheng-Shiun Leu; Paul S Appelbaum
Journal:  J Genet Couns       Date:  2012-05-15       Impact factor: 2.537

9.  Carrier screening in individuals of Ashkenazi Jewish descent.

Authors:  Susan J Gross; Beth A Pletcher; Kristin G Monaghan
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

10.  Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening.

Authors:  Jodi D Hoffman; Valerie Greger; Erin T Strovel; Miriam G Blitzer; Mark A Umbarger; Caleb Kennedy; Brian Bishop; Patrick Saunders; Gregory J Porreca; Jaclyn Schienda; Jocelyn Davie; Stephanie Hallam; Charles Towne
Journal:  Mol Genet Genomic Med       Date:  2013-09-16       Impact factor: 2.183

View more
  6 in total

1.  Whole-Exome Sequencing Identifies a Novel Homozygous Frameshift Mutation in the MTMR2 Gene as a Causative Mutation in a Patient with Charcot-Marie-Tooth Disease Type 4B1.

Authors:  Tameemi Abdalla-Moady; Amir Peleg; Orit Sadeh; Khader Badarneh; Fuad Fares
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

2.  Online Module for Carrier Screening in Ashkenazi Jewish Individuals Compared with In-Person Genetics Education: A Randomized Controlled Trial.

Authors:  Chia Wei Fan; Lysanne Castonguay; Sonja Rummell; Sébastien Lévesque; John J Mitchell; Guillaume Sillon
Journal:  J Genet Couns       Date:  2017-08-09       Impact factor: 2.537

3.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

4.  Novel recruitment strategy to enrich for LRRK2 mutation carriers.

Authors:  Tatiana Foroud; Danielle Smith; Jacqueline Jackson; Jennifer Verbrugge; Cheryl Halter; Leah Wetherill; Katherine Sims; Winnie Xin; Vanessa Arnedo; Shirley Lasch; Kenneth Marek
Journal:  Mol Genet Genomic Med       Date:  2015-05-06       Impact factor: 2.183

5.  Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases.

Authors:  Mirjam Plantinga; Erwin Birnie; Kristin M Abbott; Richard J Sinke; Anneke M Lucassen; Juliette Schuurmans; Seyma Kaplan; Marian A Verkerk; Adelita V Ranchor; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2016-05-11       Impact factor: 4.246

6.  DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).

Authors:  Lora J H Bean; Maren T Scheuner; Michael F Murray; Leslie G Biesecker; Robert C Green; Kristin G Monaghan; Glenn E Palomaki; Richard R Sharp; Tracy L Trotter; Michael S Watson; Cynthia M Powell
Journal:  Genet Med       Date:  2021-03-31       Impact factor: 8.822

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.